THURSDAY, June 27, 2024 (HealthDay News) — Want to reduce your risk of type 2 diabetes? Avoid bright light at night, a recent study suggests. More exposure to light at night, between 12:30 a.m. and 6 a.m., is linked to a higher risk of developing type 2 diabetes, researchers found.Continue Reading
WEDNESDAY, June 26, 2024 (HealthDay News) — A common plastics chemical might increase a person’s risk of diabetes, a new study warns. People fed small doses of Bisphonol A (BPA) developed significantly worse insulin sensitivity within a four-day period, researchers found. “We were surprised to see that reducing BPA exposure,Continue Reading
WEDNESDAY, June 26, 2024 (HealthDay News) — The stress hormone cortisol appears to play a role in tough-to-treat type 2 diabetes, a new study finds. About 1 in 4 people (24%) with tough-to-treat type 2 diabetes have elevated cortisol levels, researchers found. “These results are significant as they highlight aContinue Reading
WEDNESDAY, June 26, 2024 (HealthDay News) — A person’s gut microbiome appears to increase their risk of developing type 2 diabetes, researchers claim. Specific strains of gut microbes are more commonly found in people with type 2 diabetes, and these strains seem to heighten the risk of developing the metabolicContinue Reading
TUESDAY, June 25, 2024 (HealthDay News) — Losing weight can protect you against cancers related to obesity, a new study finds. Obesity has been linked to higher risk of at least 13 types of cancer, researchers said. This is largely due to excess levels of hormones like estrogen and insulin.Continue Reading
TUESDAY, June 25, 2024 (HealthDay News) — A well-established cholesterol-lowering drug appears to significantly slow the progression of a diabetes-related eye disease, a new trial shows. Fenofibrate (Tricor) has been approved since 2004 as a means of lowering cholesterol. Now, this new study shows that fenofibrate also can reduce theContinue Reading
TUESDAY, June 25, 2024 (HealthDay News) — An experimental stem cell therapy can essentially cure type 1 diabetes by restoring insulin production in some patients, early clinical trial results show. Seven out of 12 patients no longer needed daily insulin shots after receiving a full dose of the gene therapy,Continue Reading
MONDAY, June 24, 2024 (HealthDay News) — Inhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows. Patients using inhaled insulin (Afrezza) plus long-lasting insulin degludec injections had better control over their blood sugar than those assignedContinue Reading
TUESDAY, June 18, 2024 (HealthDay News) — Two new studies offer reassurance that using the diabetes drug metformin before and during pregnancy is not linked to birth defects. The latest findings, which apply to men planning to conceive with their partners or women in early pregnancy, contradict a 2022 studyContinue Reading
THURSDAY, June 13, 2024 (HealthDay News) — People with type 1 diabetes are 25% less likely to die early now than they were in 1990, a new global tally finds, and the number of people who’ve lived into their senior years with the autoimmune illness keeps rising. The new findingsContinue Reading
WEDNESDAY, June 11, 2024 (HealthDay News) — Folks trying to control their blood sugar levels might do best to work out in the evening, a new study suggests. Exercise performed between 6 p.m. and midnight appeared to be better at controlling blood sugar levels all day long, according to resultsContinue Reading
THURSDAY, June 6, 2024 (HealthDay News) — Common drugs used to control cholesterol, blood sugar and high blood pressure might also lower a person’s risk of stroke, a new study finds. The researchers evaluated the risk of brain aneurysms that cause bleeding strokes in patients. For the study, they lookedContinue Reading
MONDAY, June 3, 2024 (HealthDay News) — Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and type 2 diabetes, a new study says. Up to now, doctors have been cautious about prescribing semaglutide to patients with a history of pancreatitis, because they feared theContinue Reading
THURSDAY, May 23, 2024 (HealthDay News) — Three months after starting one of the new GLP-1 weight-loss drugs, more than a quarter of patients have already quit the medications, and by a year from first use more than a third have stopped, new research shows. Reasons for quitting Wegovy, OzempicContinue Reading